Cardiac & Pulmonary Cell Therapy
Healing the Heart and Lungs Through Cellular Regeneration
Cardiovascular and pulmonary conditions — including heart failure, coronary artery disease, COPD, and pulmonary fibrosis — are among the leading causes of death and disability worldwide. These conditions are characterized by progressive tissue damage, reduced blood flow, chronic inflammation, and declining organ function that conventional medicine often struggles to reverse.
Stem cell therapy has shown remarkable potential in repairing damaged heart tissue, improving cardiac function, and reducing lung inflammation. Mesenchymal stem cells (MSCs) can differentiate into cardiac and vascular cell types, secrete powerful growth factors that stimulate angiogenesis (new blood vessel formation), and exert anti-fibrotic effects that reduce harmful scar tissue in both heart and lungs.
At Cellf Solutions in Sanur, Bali, we offer targeted regenerative protocols that harness these mechanisms — giving patients a new option beyond medication management and toward genuine tissue repair and functional improvement.
How Stem Cell Therapy Helps Cardiac & Pulmonary Conditions
Stem cells offer multiple, synergistic mechanisms of action that directly address the underlying pathology of heart and lung disease.
Cardiac Muscle Regeneration
MSCs can differentiate into cardiomyocyte-like cells and secrete growth factors that stimulate resident cardiac stem cells, helping to repair damaged myocardium after heart attack, in heart failure, or in cardiomyopathy — improving ejection fraction and contractile function.
Angiogenesis — New Blood Vessel Formation
Stem cells release VEGF, FGF, and other angiogenic factors that stimulate the formation of new capillaries and collateral blood vessels. This improves blood supply to oxygen-starved tissues in coronary artery disease, peripheral artery disease, and ischemic cardiomyopathy.
Reduced Scar Tissue — Anti-Fibrotic Effects
After heart attack or in chronic lung disease, excessive fibrosis replaces functional tissue with stiff scar tissue. MSCs secrete matrix metalloproteinases and anti-fibrotic cytokines that remodel scar tissue, reduce stiffness, and preserve organ compliance and function.
Improved Lung Function & Reduced Inflammation
In pulmonary conditions like COPD, emphysema, and pulmonary fibrosis, MSCs reduce alveolar inflammation, suppress pro-inflammatory cytokines, and promote epithelial repair. Patients often report improved oxygenation, reduced shortness of breath, and better exercise tolerance.
Conditions We Treat Under Cardiac & Pulmonary
Our regenerative protocols are tailored to a wide range of heart and lung conditions, each with a personalized treatment plan.
Heart Failure & Cardiomyopathy
Weakened heart muscle leading to reduced pumping capacity and fluid buildup. Stem cells improve cardiac output by regenerating damaged myocardium and reducing harmful ventricular remodeling.
MyocardialCoronary Artery Disease
Narrowed or blocked coronary arteries reducing blood flow to the heart. Stem cell therapy promotes angiogenesis — growing new blood vessels that bypass blockages and restore perfusion naturally.
VascularPeripheral Artery Disease
Reduced blood flow to the limbs causing pain, non-healing wounds, and limited mobility. Stem cells stimulate new vessel formation in the legs, improving circulation and reducing risk of complications.
VascularCOPD & Emphysema
Chronic obstructive pulmonary disease causes progressive airflow limitation and breathing difficulty. MSCs reduce lung inflammation, combat alveolar destruction, and may improve lung function and exercise capacity.
PulmonaryPulmonary Fibrosis
Scarring of lung tissue that stiffens the lungs and impairs gas exchange. Stem cell therapy's anti-fibrotic properties help slow or partially reverse fibrotic scarring while reducing inflammation.
PulmonaryPost-Heart Attack Recovery
After myocardial infarction, scar tissue replaces functional heart muscle. Timely stem cell intervention can limit scar size, preserve viable myocardium, and support functional recovery in the critical post-infarction period.
Acute RecoveryOur Treatment Approach
Each patient receives a comprehensive, personalized treatment protocol carefully designed to address their specific cardiac or pulmonary condition and overall health goals.
Cardiac / Pulmonary Evaluation
Comprehensive assessment including medical history review, symptom evaluation, functional status (NYHA class, 6-minute walk test), and review of prior imaging and lab results.
Targeted Cell Delivery
Cells administered via intravenous infusion for systemic effect and/or catheter-based or targeted delivery using sterile, fully enclosed systems for maximum concentration at the site of injury.
Cardiac / Pulmonary Rehab Integration
Structured rehabilitation program integrated with cell therapy — including exercise, nutritional support, and lifestyle modification — to maximize treatment outcomes and long-term functional gains.
Experience the Future of Cardiac & Pulmonary Care
Schedule your consultation with our expert team at our partner clinic in Sanur, Bali. Discover how regenerative cell therapy can help restore your heart and lung function and improve your quality of life.
Disclaimer: When accessing the material in this website it is advised that you seek Physician advise before making any conclusions. The website contains the opinions of multiple authors and is intended for educational purposes only with the understanding the website is not providing any professional services.
